Mosaiques Diagnostics GmbH

Mosaiques Diagnostics GmbH is an SME in Hannover, Germany that has taken part in 34 EU-funded projects since 2008, receiving €14.5M in EU funding and leading 9 as coordinator.

EU funding received€14.5M
EU projects34
As coordinator9
Running now4
First EU project2008
Latest project2024
CountryGermany
EU registration (PIC)999415445
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Mosaiques Diagnostics GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€9.0M · 16 projects
  • Horizon Europe€2.8M · 5 projects
  • Horizon 2020€2.7M · 13 projects

Projects

34 EU-funded projects, newest first. Mosaiques Diagnostics GmbH led 9 of them as coordinator. Each links to the official record.

  • PICKEDPartner

    PersonalIzed medicine in Chronic KidnEy Disease

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €261ktheir share
  • PROMOTECoordinator

    PRostate cancer OMics Oriented inTErvention

    Horizon Europe · 2024–2028 · Project on CORDIS ↗

    €782ktheir share
  • MULTIRPartner

    MULti-Tumour based prediction and manipulation of Immune Response

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €737ktheir share
  • ELMUMYPartner

    Elucidation of risk factors and health determinants associated with PROGRESSION of Monoclonal Gammopathies to Multiple Myeloma

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €512ktheir share
  • DisCo-IPartner

    Discovering Collagen I degradation process in chronic diseases with fibrotic component

    Horizon Europe · 2022–2026 · Project on CORDIS ↗

    €521ktheir share
  • ReDrugBCCoordinator

    Novel therapeutic approaches, based on drug repurposing, for high risk non muscle invasive bladder cancer driven by patients’ proteomic signatures

    Horizon 2020 · 2020–2022 · Project on CORDIS ↗

    €163ktheir share
  • STRATEGY-CKDPartner

    System omics to unravel the gut-kidney axis in Chronic Kidney Disease.

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €253ktheir share
  • DC-renPartner

    Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren)

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €701ktheir share
  • PROCEEDCoordinator

    Proteomics for Chronic Kidney Disease Therapy

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

    €171ktheir share
  • PCaProTreatCoordinator

    Multi-omics molecular treatment targets for Prostate Cancer

    Horizon 2020 · 2018–2020 · Project on CORDIS ↗

    €171ktheir share
  • CaReSyAnPartner

    Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

    €249ktheir share
  • TheranOMICSCoordinator

    Integration of high resolution -OMICS datasets towards personalized therapy in bladder cancer

    Horizon 2020 · 2017–2018 · Project on CORDIS ↗

    €116ktheir share
  • BioMedBCCoordinator

    Molecular profiling of Bladder Cancer to support personalized medicine

    Horizon 2020 · 2017–2019 · Project on CORDIS ↗

    €159ktheir share
  • TransPotPartner

    Translational Research Network in Prostate Cancer

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

  • PRETREATPartner

    PRoteome-based assessment of vascular disease for the Establishment of a Translational REsearch plATform

    Horizon 2020 · 2016–2019 · Project on CORDIS ↗

    €149ktheir share
  • RENALTRACTPartner

    Development and disease of the renal tract

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €249ktheir share
  • Chromatin3DPartner

    Chromatin Dynamics in Development and Disease

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €249ktheir share
  • BioGuidePCaCoordinator

    Biomarker Guided Prostate Cancer Management

    Horizon 2020 · 2014–2015 · Project on CORDIS ↗

    €50ktheir share
  • SYSVASCPartner

    Systems Biology to Identify Molecular Targets for Vascular Disease Treatment

    FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗

    €884ktheir share
  • TRANSBIOBCPartner

    Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction

    FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗

    €1.1Mtheir share
  • IMODE-CKDPartner

    Clinical and system –omics for the identification of the MOlecular DEterminants of established Chronic Kidney Disease

    FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

    €418ktheir share
  • BIOMARGINPartner

    Biomarkers of renal graft injuries in kidney allograft recipients

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €256ktheir share
  • HOMAGEPartner

    Heart OMics in AGEing

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

    €864ktheir share
  • FRAILOMICPartner

    Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative

    FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗

    €600ktheir share
  • TRANCYSTPartner

    Translational research (training) in Polycystic Kidney Disease

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €224ktheir share
  • EURENOMICSPartner

    European Consortium for High-Throughput Research in Rare Kidney Diseases

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €345ktheir share
  • CodeAgePartner

    The role of Chronic DNA damage in Ageing and Age-related pathology

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €222ktheir share
  • BCMolMedCoordinator

    Molecular Medicine for Bladder Cancer

    FP7 (2007 to 2013) · 2012–2016 · Project on CORDIS ↗

    €444ktheir share
  • PRIORITYPartner

    Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €1.5Mtheir share
  • EU-MASCARAPartner

    Markers for Sub-Clinical Cardiovascular Risk Assessemnt

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €789ktheir share
  • HEPACUTEPartner

    Host and viral factors in acute hepatitis C

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €123ktheir share
  • PROTOCLINCoordinator

    IMPROVEMENT OF TOOLS AND PORTABILITY OF MASS SPECTROMETRY-BASED CLINICAL PROTEOMICS AS APPLIED TO CHRONIC KIDNEY DISEASE

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €356ktheir share
  • SYSKIDPartner

    Systems biology towards novel chronic kidney disease diagnosis and treatment

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €662ktheir share
  • GENINCAPartner

    Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer

    FP7 (2007 to 2013) · 2008–2011 · Project on CORDIS ↗

    €244ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • HIV
  • RNA
  • bladder cancer
  • cardiology
  • cardiovascular diseases
  • catalysis
  • chromosomes
  • colorectal cancer
  • databases
  • diabetes
  • diabetic nephropathy
  • drug discovery
  • electrophoresis

Mosaiques Diagnostics GmbH is listed on EUACC

See the startup profile for its product, team and what it is looking for.

Open the startup profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime